Daniel H Zimmerman

Awards Nomination 20+ Million Readerbase

PMC/PubMed Indexed Articles

Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation

MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA

Google Scholar citation report

Citations : 2051

Journal of Vaccines & Vaccination received 2051 citations as per Google Scholar report

Journal of Vaccines & Vaccination peer review process verified at publons

25+ Million Website Visitors

Indexed In

Academic Journals Database
Open J Gate
Genamics JournalSeek
JournalTOCs
China National Knowledge Infrastructure (CNKI)
Scimago
Ulrich's Periodicals Directory
RefSeek
Hamdard University
EBSCO A-Z
OCLC- WorldCat
Publons
MIAR
University Grants Commission
Geneva Foundation for Medical Education and Research
Euro Pub
Google Scholar

Useful Links

Share This Page

Tweets by Vaccine41931315

Open Access Journals

Daniel H Zimmerman

Daniel H Zimmerman

CEL-SCI Corporation 8229 Boone Blvd suite 802, Vienna,VA 22182, USA.

Biography

Dr. Daniel H. Zimmerman, Ph.D. has been a Senior Vice President of Research - Cellular Immunology at CEL-SCI Corporation since October 2009. Dr. Zimmerman served as Senior Vice President of Research and Cellular Immunology from January 1996 to December 2008. Dr. Zimmerman founded CELL-MED, Inc. and was its President from 1987 to 1995. From 1973 to 1987, Dr. Zimmerman served in various positions at Electronucleonics, as Scientist.